Validation of an HPLC Method for the Pharmacokinetic Study of Glipizide in Human |
Cho, Hea-Young
(College of Pharmacy, Chonnam National University)
Lee, Hwa-Jeong (College of Pharmacy, Ewha Womans University) Choi, Hoo-Kyun (College of Pharmacy, Chosun University) Lee, Yong-Bok (College of Pharmacy, Chonnam National University) |
1 | S. Dhawan and A.K. Singla, Performance liquid chromatographic analysis of glipizide: application to in vitro and in vivo studies, J. Chromatogr. Sci., 41(6), 295-300 (2003) DOI ScienceOn |
2 | Y.J. Lee, S.J. Chung and C.K. Shim, Bioavailability Analysis Program BA Calc. 2002 for Windows, Ver. 1.1.1, Seoul National University, Seoul, Korea (2002) |
3 | Users Guide Ver. 3.0, Pharsight Corp. Mountain View, CA, USA (1998-1999). |
4 | H. Emilsson, High-performance liquid chromatographic determination of glipizide in human plasma and urine, J. Chromatogr., 421, 319-326 (1987) DOI ScienceOn |
5 | L. Balant, Clinical pharmacokinetics of sulphonylurea hypo-glycemic drugs, Clin. Pharmacokinet., 6, 215-241 (1981) DOI ScienceOn |
6 | Martindale, The complete drug reference, 32nd Eds., p. 320 (1999) |
7 | J. Kirchheiner and J. Brockmoller, Clinical consequences of cytochrome P4502C9 polymorphisms, Clin. Pharmacol. Ther., 77, 1-16 (2005) DOI ScienceOn |
8 | R.S. Kidd, A.B. Straughn, M.C. Meyer, J.A. Goldstein and J.T. Dalton, Phartnacokinetics of chlorpheniramine, phenytoin, glipizicle, and nifedipine in an individual homozygous for the CYP2C9*3 allele, Pharmacogenetics, 9, 71-80 (1999) DOI ScienceOn |
9 | J.O. Miner and D.J. Birkett, Cytochrome P4502C9: an enzyme of major importance in human drug metabolism, Br. J. Pharmacol., 45, 525-538 (1998) DOI ScienceOn |
10 | 식품의약품안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22) |